← Research library

Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry

Laboratory analysis · 2010

What was studied
Human plasma and healthy volunteers
Main finding
Validated an LC-MS/MS assay and applied it to human pharmacokinetics. Plasma detection does not establish brain delivery or cognitive benefit.

Linear analyte range · 1–5,000 ng/mL

Reported findings and study design

Human-plasma analytical LC-MS/MS method; mobile phase methanol/ammonium-acetate/formic acid 55:45:01 as printed; flow 0.65 mL/min.

Population or model Human plasma and healthy volunteers

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Linear analyte range1–5,000 ng/mL
Lower quantification limit1 ng/mL
Intra/inter-assay precisionBelow 13.5%
Accuracy99.6–101.6%
Analyte mass transitionsm/z 209 → 78 + 106Internal standard: paracetamol 152 → 93 + 110

Method-validation accuracy is not a Picamilon treatment-response percentage. Human pharmacokinetic values were not supplied in the abstract.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Full methods and risk of bias have not been appraised.
  • These findings do not establish long-term, combination or hazardous-work safety.
  • Related reports may share participants; source records are not independent-trial counts.

Source details

Indexed citation and abstract checked through Europe PMC; full paper not reviewed.

Sources checked

Citation

Analytical / composition studyEnglish abstract

Cui W, Chen X, Zhan Y, Zhang Z, Zhang Y, Zhong D. Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 878(15-16). PMID 20359966

Study source ↗ · DOI 10.1016/j.jchromb.2010.03.013 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards